Your account is not claimed yet. You can sign up with ORCID to claim your account.

Masoud Jamei

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

CPT: pharmacometrics & systems pharmacology

Molecular pharmaceutics

Pharmaceutics

Clinical pharmacology and therapeutics

Certara UK

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Certara UK Oct 13o 2003

United Kingdom

Senior Vice President :: Research and Development

Publications

Ben G Small, Oliver Hatley, Masoud Jamei, Iain Gardner, Trevor N Johnson
Incorporation and performance verification of hepatic portal blood flow shunting in minimal and full PBPK models of liver cirrhosis. Clinical pharmacology and therapeutics (2023)
Iain Gardner, Mandy Xu, Chunyan Han, Yi Wang, Xingjin Jiao, Masoud Jamei, Hiba Khalidi, Peter J Kilford, Sibylle Neuhoff, Roz Southall, David B Turner, Helen Musther, Barry Jones, Simon J Taylor
Non-specific binding of compounds in in vitro metabolism assays: A comparison of microsomal and hepatocyte binding in different species and an assessment of the accuracy of prediction models. Xenobiotica; the fate of foreign compounds in biological systems (2022)
Nikunjkumar Patel, James F Clarke, Farzaneh Salem, Tariq Abdulla, Frederico Severino Martins, Sumit Arora, Eleftheria Tsakalozou, Arran Hodgkinson, Omid Arjmandi-Tash, Sinziana Cristea, Priyanka Ghosh, Khondoker Alam, Sam G Raney, Masoud Jamei, Sebastian Polak
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)
Janak R Wedagedera, Anthonia Afuape, Siri Kalyan Chirumamilla, Hiroshi Momiji, Robert Leary, Mike Dunlavey, Richard Matthews, Khaled Abduljalil, Masoud Jamei, Frederic Y Bois
Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers. CPT: pharmacometrics & systems pharmacology 11 (6) (2022)
Sumit Arora, James F Clarke, Eleftheria Tsakalozou, Priyanka Ghosh, Khondoker Alam, Jeffery E Grice, Michael S Roberts, Masoud Jamei, Sebastian Polak
Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model. Molecular pharmaceutics 19 (9) (2022)
Siri Kalyan Chirumamilla, Venkatesh Teja Banala, Masoud Jamei, David B Turner
Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents. Pharmaceutics 13 (8) (2021)
Helen Humphries, Lisa Almond, Alexander Berg, Iain Gardner, Oliver Hatley, Xian Pan, Ben G Small, Mian Zhang, Masoud Jamei, Klaus Romero
Development of physiologically-based pharmacokinetic models for standard of care and newer tuberculosis drugs. CPT: pharmacometrics & systems pharmacology 10 (11) (2021)
Sumit Arora, Amita Pansari, Peter Kilford, Masoud Jamei, Iain Gardner, David B Turner
Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State Conditions. Molecular pharmaceutics 17 (7) (2020)
Ioannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Masoud Jamei, David Turner, Jennifer Dressman
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. Pharmaceutics 12 (11) (2020)
Anam Fayyaz, Veli-Pekka Ranta, Elisa Toropainen, Kati-Sisko Vellonen, Giuseppe D'Amico Ricci, Mika Reinisalo, Emma M Heikkinen, Iain Gardner, Arto Urtti, Masoud Jamei, Eva M Del Amo
Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits. Molecular pharmaceutics 17 (2) (2020)
Mark McAllister, Talia Flanagan, Karin Boon, Xavier Pepin, Christophe Tistaert, Masoud Jamei, Andreas Abend, Evangelos Kotzagiorgis, Claire Mackie
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory Perspectives. Pharmaceutics 12 (1) (2019)

Masoud Jamei.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masoud Jamei